32nd Annual Miami Breast Cancer Conference®
32nd Annual Miami Breast Cancer Conference®February 26, - March 1, 2015
Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140
The optimal care of patients with breast cancer is rapidly changing as a result of advances in all aspects of patient care, including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies. There is an increasing focus on providing multidisciplinary care for patients with complex diseases such as breast cancer through the use of integrated teams of professionals representing the relevant treatment modalities, including surgery, radiation therapy, and systemic medical interventions. The multidisciplinary Miami Breast Cancer Conference®
has been bringing together surgical, medical, and radiation oncologists for 32 years, with the aim of fostering awareness of the state-of-the-art treatments in each therapeutic area and encouraging crossteam cooperation in the clinic. At the 32nd Annual Miami Breast Cancer Conference®
, pioneers of innovative approaches in each of these subspecialties will provide insight into the optimal multidisciplinary management of patients with breast cancer and its application to practice.
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
The 32nd Annual Miami Breast Cancer Conference®
Mini-Symposium offers an additional educational opportunity for attendees who plan to arrive in Miami the day before the official conference begins. The Mini-Symposium takes the format of a World-Class Tumor Board, featuring cases and discussions that highlight challenging clinical situations commonly faced by surgeons and oncologists, including:
The value of excision when LCIS is found at core needle biopsy
Breast-conservation therapy by tumor biologic subtype
The challenge of pain management
Defining and managing invasive lobular carcinoma
Regional node irradiation in sentinel node–positive disease
Contemporary issues in lymphedema
Therapy for intermediate-risk ER-positive, HER2-negative tumors
This special session was developed to be of interest to healthcare practitioners from all specialties, and will provide practical information to enhance patient care in the clinic, delivered by top experts in the field of breast cancer. If your schedule allows, we hope you will plan to attend and take advantage of this extra session!
Note: Separate registration is required.
Patrick I. Borgen, MD
Chairman, Department of Surgery
Director, Brooklyn Breast Cancer Program
J. Michael Dixon, MD
OBE Professor of Surgery & Consultant Surgeon
Clinical Director, Breakthrough Research Unit
Edinburgh Breast Unit
Hyman B. Muss, MD
Professor of Oncology
University of North Carolina
Director of Geriatric Oncology
Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Debu Tripathy, MD
Professor of Medicine and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Joan Lunden is an award winning journalist, best-selling author, television host, and health advocate. As host of ABC’s Good Morning America for nearly two decades, Lunden is the longest running host ever on early morning television. As an entrepreneur Lunden has created a brand dedicated to helping families live easier, happier, and healthier lives through her product lines, books, and health and wellness website JoanLunden.com
. There, Joan has been sharing her breast cancer journey as well as articles on health, wellness, lifestyle, caregiving, and boomers.